Evaluation of systemic Rituximab for treating orbital MALT lymphoma
Not Applicable
Recruiting
- Conditions
- Orbital MALT lymphoma
- Registration Number
- JPRN-UMIN000009512
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who have history of myocardial infarction and brain infarction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method best-corrected visual acuity, intraocular pressure, indirect ophthalmoscopy, and slit-lamp examination before and after every treatment
- Secondary Outcome Measures
Name Time Method